+ Site Statistics
+ Search Articles
+ PDF Full Text Service
How our service works
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ Translate
+ Recently Requested

Comprehensive geriatric assessment is an essential tool to support treatment decisions in elderly patients with diffuse large B-cell lymphoma: a prospective multicenter evaluation in 173 patients by the Lymphoma Italian Foundation (FIL)



Comprehensive geriatric assessment is an essential tool to support treatment decisions in elderly patients with diffuse large B-cell lymphoma: a prospective multicenter evaluation in 173 patients by the Lymphoma Italian Foundation (FIL)



Leukemia and Lymphoma 56(4): 921-926



We performed a multicenter study to validate the concept that a simple comprehensive geriatric assessment (CGA) can identify elderly, non-fit patients with diffuse large B-cell lymphoma (DLBCL) in whom curative treatment is not better then palliation, and to analyze potential benefits of treatment modulation after further subdividing the non-fit category by CGA criteria. One hundred and seventy-three patients aged > 69 treated with curative or palliative intent by clinical judgement only were grouped according to CGA into fit (46%), unfit (16%) and frail (38%) categories. Two-year overall survival (OS) was significantly better in fit than in non-fit patients (84% vs. 47%; p < 0.0001). Survival in unfit and frail patients was not significantly different. Curative treatment slightly improved 2-year OS in unfit (75% vs. 45%) but not in frail patients (44% vs. 39%). CGA was confirmed as very efficient in identifying elderly patients with DLBCL who can benefit from a curative approach. Further efforts are needed to better tailor therapies in non-fit patients.

Please choose payment method:






(PDF emailed within 0-6 h: $19.90)

Accession: 052270633

Download citation: RISBibTeXText

PMID: 25110825

DOI: 10.3109/10428194.2014.953142


Related references

The Elderly Project By The Fondazione Italiana Linfomi: A Prospective Comprehensive Geriatric Assessment (Cga) Of 1353 Elderly Patients With Diffuse Large B-Cell Lymphoma. Hematological Oncology 37: 248-250, 2019

Validation and Refinement of the Age, Comorbidities, and Albumin Index in Elderly Patients with Diffuse Large B-Cell Lymphoma: An Effective Tool for Comprehensive Geriatric Assessment. Oncologist 23(6): 722-729, 2018

Role of anthracycline and comprehensive geriatric assessment for elderly patients with diffuse large B-cell lymphoma. Blood 130(20): 2180-2185, 2017

Analysis of elderly patients with diffuse large B-cell lymphoma: aggressive therapy is a reasonable approach for 'unfit' patients classified by comprehensive geriatric assessment. European Journal of Haematology 96(4): 409-416, 2016

Modulated chemotherapy according to modified comprehensive geriatric assessment in 100 consecutive elderly patients with diffuse large B-cell lymphoma. Oncologist 17(6): 838-846, 2012

Comprehensive geriatric assessment can predict the clinical outcomes of elderly patients with diffuse large B cell lymphoma in China. Zhonghua Xue Ye Xue Za Zhi 39(4): 271-276, 2018

A comprehensive geriatric assessment is more effective than clinical judgment to identify elderly diffuse large cell lymphoma patients who benefit from aggressive therapy. Cancer 115(19): 4547-4553, 2009

Lin RJ, Behera M, Diefenbach CS, Flowers CR. Role of anthracycline and comprehensive geriatric assessment for elderly patients with diffuse large B-cell lymphoma. Blood. 2017;130(20):2180-2185. Blood 131(9): 1037-1037, 2018

Outcome of frail elderly patients with diffuse large B-cell lymphoma prospectively identified by Comprehensive Geriatric Assessment: results from a study of the Fondazione Italiana Linfomi. Leukemia and Lymphoma 55(1): 38-43, 2014

An oral chemotherapy regimen for the treatment of diffuse large cell lymphoma in elderly patients The experience of the Italian Lymphoma Intergroup. Proceedings of the American Association for Cancer Research Annual Meeting 44: 184, 2003

Treatment decisions and outcome in very elderly patients with diffuse large B-cell lymphoma. Cancer 121(20): 3746-3747, 2015

CIEP An Oral Chemotherapy Regimen Devised for Diffuse Large Cell Lymphoma in Elderly Patients An Interim Report from Italian Lymphoma Intergroup. Blood 100(11): Abstract No 4725, November 16, 2002

R08The Elderly Project by the Fondazione Italiana Linfomi (Fil): a prospective multidimensional assessment of elderly patients with diffuse large B-cell lymphoma. Annals of Oncology 26(Suppl 6): vi.223-vi, 2015

A retrospective study on 73 elderly patients (≥75years) with aggressive B-cell non Hodgkin lymphoma: clinical significance of treatment intensity and comprehensive geriatric assessment. Journal of Geriatric Oncology 4(3): 242-248, 2014

Bendamustine with or without rituximab for the treatment of heavily pretreated non-Hodgkin's lymphoma patients : A multicenter retrospective study on behalf of the Italian Lymphoma Foundation (FIL). Annals of Hematology 91(7): 1013-1022, 2012